| Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ... Nature genetics 51 (3), 414-430, 2019 | 2186 | 2019 |
| The genome of the model beetle and pest Tribolium castaneum. S Richards, RA Gibbs, GM Weinstock, SJ Brown, R Denell, RW Beeman, ... Nature 452 (7190), 949-955, 2008 | 1432 | 2008 |
| Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease C Cruchaga, CM Karch, SC Jin, BA Benitez, Y Cai, R Guerreiro, O Harari, ... Nature 505 (7484), 550-554, 2014 | 523 | 2014 |
| Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control National Collaborating Centre for Chronic Conditions (Great Britain) Royal College of Physicians, 2006 | 388 | 2006 |
| Evidence for 28 genetic disorders discovered by combining healthcare and research data J Kaplanis, KE Samocha, L Wiel, Z Zhang, KJ Arvai, RY Eberhardt, ... Nature 586 (7831), 757-762, 2020 | 381 | 2020 |
| GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence M Brunetti, I Shemilt, S Pregno, L Vale, AD Oxman, J Lord, J Sisk, F Ruiz, ... Journal of clinical epidemiology 66 (2), 140-150, 2013 | 292 | 2013 |
| The EQ-5D-5L health status questionnaire in COPD: validity, responsiveness and minimum important difference CM Nolan, L Longworth, J Lord, JL Canavan, SE Jones, SSC Kon, ... Thorax 71 (6), 493-500, 2016 | 248 | 2016 |
| Newborn screening for inborn errors of metabolism: a systematic review. CA Seymour, MJ Thomason, RA Chalmers, GM Addison, MD Bain, ... Health technology assessment (Winchester, England) 1 (11), i-iv, 1-95, 1996 | 224 | 1996 |
| Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial DA Fennell, S Ewings, C Ottensmeier, R Califano, GG Hanna, K Hill, ... The Lancet Oncology 22 (11), 1530-1540, 2021 | 197* | 2021 |
| Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study I Abubakar, F Drobniewski, J Southern, AJ Sitch, C Jackson, M Lipman, ... The Lancet Infectious Diseases 18 (10), 1077-1087, 2018 | 189 | 2018 |
| Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families N Akawi, J McRae, M Ansari, M Balasubramanian, M Blyth, AF Brady, ... Nature genetics 47 (11), 1363-1369, 2015 | 164 | 2015 |
| Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials E Liu, ME Schmidt, R Margolin, R Sperling, R Koeppe, NS Mason, ... Neurology 85 (8), 692-700, 2015 | 164 | 2015 |
| Exercises to improve function of the rheumatoid hand (SARAH): a randomised controlled trial SE Lamb, EM Williamson, PJ Heine, J Adams, S Dosanjh, M Dritsaki, ... The Lancet 385 (9966), 421-429, 2015 | 149 | 2015 |
| Weekend specialist intensity and admission mortality in acute hospital trusts in England: a cross-sectional study C Aldridge, J Bion, A Boyal, YF Chen, M Clancy, T Evans, A Girling, J Lord, ... The Lancet 388 (10040), 178-186, 2016 | 133 | 2016 |
| Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance HA Wai, J Lord, M Lyon, A Gunning, H Kelly, P Cibin, EG Seaby, ... Genetics in Medicine 22 (6), 1005-1014, 2020 | 131 | 2020 |
| Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. F Drobniewski, M Cooke, J Jordan, N Casali, T Mugwagwa, A Broda, ... Health technology assessment (Winchester, England) 19 (34), 1-viii, 2015 | 128 | 2015 |
| Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis N Latimer, J Lord, RL Grant, R O’Mahony, J Dickson, PG Conaghan BMJ 339, 2009 | 117 | 2009 |
| Evidence-based decision making: when should we wait for more information? K Chalkidou, J Lord, A Fischer, P Littlejohns Health Affairs 27 (6), 1642-1653, 2008 | 102 | 2008 |
| Cost-effectiveness of digital photographic screening for retinopathy of prematurity in the United Kingdom MC Castillo-Riquelme, J Lord, MJ Moseley, AR Fielder, L Haines International journal of technology assessment in health care 20 (2), 201-213, 2004 | 91 | 2004 |
| Prenatal Assessment of Genomes and Exomes Consortium. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study J Lord, DJ McMullan, RY Eberhardt, G Rinck, SJ Hamilton, ... Lancet 393 (10173), 747-757, 2019 | 88 | 2019 |
Martin UnderwoodProfessor of Primary Care ResearchVerified email at warwick.ac.uk
